Ascendis Pharma (ASND) Reports Q3 Loss of EUR0.30/Share

Ascendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR0.30), versus (EUR0.18) reported last year. Revenue for the quarter came in at EUR2.1 million, versus EUR3.3 million reported last year.

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Zhongchao to execute 1-for-3 share consolidation on Nasdaq
• BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance